UCB, a global biopharmaceutical company, today announced positive data from studies involving its investigational pyrimidine nucleoside therapy, doxecitine (dC) and doxribtimine (dT), in people living ...

The collaboration between Muscular Dystrophy UK, the leading charity for over 110,000 people in the UK living with one of ...

Belgium’s largest drugmaker UCB (Euronext: UCB) today announced positive data from studies involving its investigational ...

UCB, a global biopharmaceutical company, today announced positive data from studies involving its investigational pyrimidine nucleoside therapy, doxecitine (dC) and doxribtimine (dT), in people living ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

BRUSSELS, March 19, 2025 /PRNewswire/ -- UCB, a global biopharmaceutical company, today announced positive data from studies involving its investigational pyrimidine nucleoside therapy, doxecitine ...

A grandmother joined her son and some family friends to abseil 100 feet down from the Falkirk Wheel to raise vital cash for ...

Differentiated development program includes two Nkarta clinical trials and two investigator-sponsored trials of NKX019 in rheumatic and ...

Justin Bonny relies on Medicaid for in-home nursing and personal care services, which allow him to live at home. "It's very important to me to have that freedom and independence,” said Bonny ...

Independence is everything to Justin Bonny. The 21-year-old lives at home with his family in Barrington and works at the Dover Housing Authority, helping out with after-school programs. He’s a ...

Novartis has reached an agreement to take control of Kate Therapeutics, a developer of gene therapies for inherited neuromuscular diseases, including Duchenne muscular dystrophy (DMD). The ...